Lower risk of death linked with access to key attributes of primary care, UC Davis study shows

 

Findings support "medical home" movement to improve health outcomes

 

Sacramento, Calif., USA (January 9, 2012) Greater access to features of high-quality primary care — comprehensiveness, patient-centeredness and extended office hours — is associated with lower mortality, according to a new national UC Davis study. Published in the January-February issue of the Annals of Family Medicine, the research is the first to link the availability of three specific attributes of primary care with reduced risk of death.

 

"There are a number of studies that found lower mortality risk in geographic areas with relatively high concentrations of primary-care physicians, but these associations were not necessarily applicable to individual patients within those geographic areas," said Anthony Jerant, professor of family and community medicine at UC Davis and lead author of the study. "These studies also defined ‚primary care‘ by physician specialty rather than by specific aspects of health care. We wanted to know if patients who reported having access to critical elements of primary care had lower mortality risk."

 

In conducting the study, Jerant and his colleagues used data from the 2000-05 Medical Expenditure Panel Surveys, which are large-scale surveys of people living in the U.S. and their health and health care. The study used data for 52,241 respondents aged 18 to 90 years for whom mortality information was available and who had one particular doctor’s office or clinic they visited for health information and treatment.

 

The researchers analyzed respondents‘ reported access to three primary health-care attributes:

 

  • Comprehensiveness, which includes the provision of care for new health problems, preventive care and referrals to other health-care professionals
  • The availability of evening and weekend office hours
  • Patient-centeredness, meaning that their health-care provider listened to and sought the patient’s advice when deciding on treatments

 

The researchers found that after adjusting for age, health status, weight, tobacco use and other health characteristics, greater reported access to the primary-care attributes was associated with significantly lower mortality (hazard ratio 0.79) during up to six years of follow-up.

 

"Our findings suggest that ongoing efforts to provide all Americans with a ‚medical home‘ offering the primary-care attributes we studied could yield major public health benefits," said Jerant, referring to the national movement to ensure access to patient-centered, comprehensive and continuously available primary-care services.

 

The team also found evidence that racial/ethnic minorities, poorer and less educated individuals, and those lacking health insurance reported significantly lower access to the primary-care attributes than others.

 

As a result, Jerant and his colleagues in their study wrote, "Although the wider adoption of primary care attributes may have promise for mitigating health disparities, interventions to promote equitable access to such attributes may be required to fulfill this promise."

 

In addition to Jerant, authors of the study were Joshua Fenton and Peter Franks of UC Davis. A copy of their study, "Primary Care Attributes and Mortality: A National Person-Level Study," is available at www.annfammed.org

 

The UC Davis Department of Family and Community Medicine provides comprehensive, compassionate and personal care for patients within the context of family and community. The medical team integrates a humanistic approach to treating the "whole person" with evidence-based care. Special areas of faculty research are health-behavior change, physician-patient communication, chronic-illness care, women’s health issues, and reducing racial and ethnic health disparities. For information, visit the department’s website

 

 


UC Davis Health System, 10.01.2012 (tB).

MEDICAL NEWS

IU School of Medicine researchers develop blood test for anxiety
COVID-19 pandemic increased rates and severity of depression, whether people…
COVID-19: Bacterial co-infection is a major risk factor for death,…
Regenstrief-led study shows enhanced spiritual care improves well-being of ICU…
Hidden bacteria presents a substantial risk of antimicrobial resistance in…

SCHMERZ PAINCARE

Hydromorphon Aristo® long ist das führende Präferenzpräparat bei Tumorschmerz
Sorgen und Versorgen – Schmerzmedizin konkret: „Sorge als identitätsstiftendes Element…
Problem Schmerzmittelkonsum
Post-Covid und Muskelschmerz
Kopfschmerz bei Übergebrauch von Schmerz- oder Migränemitteln

DIABETES

Wie das Dexom G7 abstrakte Zahlen mit Farben greifbar macht…
Diabetes mellitus: eine der großen Volkskrankheiten im Blickpunkt der Schmerzmedizin
Suliqua®: Einfacher hin zu einer guten glykämischen Kontrolle
Menschen mit Diabetes während der Corona-Pandemie unterversorgt? Studie zeigt auffällige…
Suliqua® zur Therapieoptimierung bei unzureichender BOT

ERNÄHRUNG

Positiver Effekt der grünen Mittelmeerdiät auf die Aorta
Natriumaufnahme und Herz-Kreislaufrisiko
Tierwohl-Fleisch aus Deutschland nur mäßig attraktiv in anderen Ländern
Diät: Gehirn verstärkt Signal an Hungersynapsen
Süßigkeiten verändern unser Gehirn

ONKOLOGIE

Strahlentherapie ist oft ebenso effizient wie die OP: Neues vom…
Zanubrutinib bei chronischer lymphatischer Leukämie: Zusatznutzen für bestimmte Betroffene
Eileiter-Entfernung als Vorbeugung gegen Eierstockkrebs akzeptiert
Antibiotika als Störfaktor bei CAR-T-Zell-Therapie
Bauchspeicheldrüsenkrebs: Spezielle Diät kann Erfolg der Chemotherapie beeinflussen

MULTIPLE SKLEROSE

Multiple Sklerose: Aktuelle Immunmodulatoren im Vergleich
Neuer Biomarker für Verlauf von Multipler Sklerose
Multiple Sklerose: Analysen aus Münster erhärten Verdacht gegen das Epstein-Barr-Virus
Aktuelle Daten zu Novartis Ofatumumab und Siponimod bestätigen Vorteil des…
Multiple Sklerose durch das Epstein-Barr-Virus – kommt die MS-Impfung?

PARKINSON

Meilenstein in der Parkinson-Forschung: Neuer Alpha-Synuclein-Test entdeckt die Nervenerkrankung vor…
Neue Erkenntnisse für die Parkinson-Therapie
Cochrane Review: Bewegung hilft, die Schwere von Bewegungssymptomen bei Parkinson…
Technische Innovationen für eine maßgeschneiderte Parkinson-Diagnostik und Therapie
Biomarker und Gene: neue Chancen und Herausforderungen für die Parkinson-Diagnose…